PRESS RELEASE

from ONXEO (EPA:ALONX)

Inside Information / Other news releases

VALERIO THERAPEUTICS 

Société anonyme à conseil d’administration au capital social de 21.610.998,20 euros

 Siège social : 49 boulevard du Général Martial Valin, 75015 Paris

410 910 095 R.C.S. Paris

image

LIST OF THE BOARD MEMBERS

POSITIONS HELD IN OTHER COMPANIES

As of March 19, 2025

 

 

Name of Director

 

 

 

Other offices and functions

 

 

 

Julien MIARA

Chief Executive Officer and Director

 

•  Managing Director at Invus

•  Director of Sensorion

•  Director of Versity

 

Jacques MALLET

Director and Chairman of the Board 

•  Chairman of Gamma-X Corporate Advisory

•  Director of Technoflex

•  Director of the Fournier Majoie Foundation

 

FINANCIERE DE LA MONTAGNE, represented by Nicolas TREBOUTA

Director

•  Manager of SARL Financière de la Montagne

•  Manager of SCI Fleurus Immobilier

•  Chairman of SAS Dragon 8

•  Managing partner of SC Financière des Associés 

•  Chairman of the Supervisory Board of SCA

Chevrillon & Associés 

•  Manager of EARL Ferme de Bissy 

•  Managing partner of SC Valois

•  Co-manager of SC Aster

•  Managing partner of SCI du Chardonnet

 

Bryan GIRAUDO

Director

•                      Chief Operating Officer and Chief Financial Officer of Gossamer Bio Inc 

•                      Director of Protagonist Therapeutics

•                      Senior Managing Director at Leerink Partners

 

Antoine BAROUKY

Chief Operating Officer and Director

•  Chairman & CEO of MAAsiRNA

•  Chairman & CEO of AB Global Strategy

•  Venture Partner at Invus

 

Shefali AGARWAL

Director

 

•                      Member of the Board of Directors of ITB Med

(unlisted)

•                      Member of the Board of Directors of Gritstone Bio

(Nasdaq: GTRS)

•                      Member of the Board of Directors of Fate Therapeutics (Nasdaq: FATE)

See all ONXEO news